CD36 and acute myeloid leukemia: CD36+ LSC shows a metabolic dependency for GAT‐associated FA release and their treatment‐resistant phenotype could be rescued by CD36 knockdown; demonstrating the specific role of FA pathways in AML drug resistance as previously suggested.78